marketcap
Facebook
Twitter
Telegram
Report an ErrorSeneca Biopharma, Inc. Financial Ratios 2011-2024 | SNCA
Annual Financial Ratios Seneca Biopharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.1 | -0.2 | -0.3 | -0.2 | -0.6 | -2.0 | -2.0 | -1.2 | -0.6 |
P/S |
39.8 | 27.6 | 4.1 | 15.4 | 253.4 | 1134.0 | 2389.1 | 354.8 | 30.2 | 20.6 |
EV/EBITDA |
0.9 | 0.6 | 0.6 | 0.2 | 0.5 | -0.6 | -2.4 | -2.2 | -0.5 | -0.4 |
PEG |
0.0 | -0.0 | -0.0 | -0.0 | -0.01 | -0.05 | -0.54 | 0.03 | -0.04 | -0.02 |
P/B |
0.1 | 0.1 | 0.2 | 0.5 | 0.4 | 2.4 | 2.5 | 4.6 | 1.8 | 4.9 |
P/CF |
-0.1 | -0.1 | -0.1 | -0.3 | -0.3 | -0.6 | -3.7 | -3.5 | -1.4 | -0.9 |
ROE % |
-166.53 | -162.93 | -81.40 | -183.98 | -185.99 | -420.83 | -127.71 | -235.58 | -145.16 | -754.21 |
ROA % |
-124.66 | -126.85 | -64.09 | -112.83 | -93.23 | -138.91 | -75.82 | -102.15 | -115.67 | -306.36 |
ROCE % |
-108.46 | -161.07 | -124.52 | -107.58 | -135.14 | -224.49 | -67.49 | -92.93 | -145.22 | -782.64 |
DSO |
- | 499.4 | 502.6 | 521.6 | 1428.3 | 1307.5 | 4370.9 | 33.2 | 3.0 | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency